Canada
· Delayed Price · Currency is CAD TSXV: EBM Statistics
Total Valuation
Eastwood Bio-Medical Canada has a market cap or net worth of CAD 37.20 million. The enterprise value is 37.25 million.
| Market Cap | 37.20M |
| Enterprise Value | 37.25M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Eastwood Bio-Medical Canada has 68.89 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 68.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | n/a |
| Float | 20.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 56.92 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -76.94 |
| EV / Sales | 57.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.84 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -64.15% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.60 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.82% in the last 52 weeks. The beta is 0.35, so Eastwood Bio-Medical Canada's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -1.82% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 33.73 |
| Average Volume (20 Days) | 1,357 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Eastwood Bio-Medical Canada had revenue of CAD 653,544 and -484,159 in losses. Loss per share was -0.01.
| Revenue | 653,544 |
| Gross Profit | 407,049 |
| Operating Income | -418,063 |
| Pretax Income | -484,159 |
| Net Income | -484,159 |
| EBITDA | -415,748 |
| EBIT | -418,063 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 13,015 in cash and 64,996 in debt, giving a net cash position of -51,981 or -0.00 per share.
| Cash & Cash Equivalents | 13,015 |
| Total Debt | 64,996 |
| Net Cash | -51,981 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.14M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.40M |
Cash Flow
| Operating Cash Flow | -4,720 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.28%, with operating and profit margins of -63.97% and -74.08%.
| Gross Margin | 62.28% |
| Operating Margin | -63.97% |
| Pretax Margin | -74.08% |
| Profit Margin | -74.08% |
| EBITDA Margin | -63.61% |
| EBIT Margin | -63.97% |
| FCF Margin | n/a |
Dividends & Yields
Eastwood Bio-Medical Canada does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.30% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Eastwood Bio-Medical Canada has an Altman Z-Score of -12.5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.5 |
| Piotroski F-Score | n/a |